Published: 2021-11-24

The acceptability of COVID-19 vaccination during spring crisis in Myanmar

Yadanar Aung, Zaw Z. Htun, Roy R. Marzo


Background: During the spring crisis, the coup and COVID-19 have led to a weakening vaccination program and Myanmar’s coronavirus prevention measures have been collapsed. The objective of this study was to determine the COVID-19 vaccine acceptance and assess its associated factors among the general adult population in Myanmar.

Methods: A cross-sectional, web-based survey was conducted with a total of 301 participants. The association between vaccine acceptability and its determinants was assessed by binary logistic regression analysis.

Results: The majority (90.4%) responded that they would like to accept vaccination if it is successfully developed and approved for listing in the future. Among the respondents, two-fifths (40.5%) had already received 1st dose of the COVID-19 vaccine, and 86.4% of the respondents thought that doctor’s recommendation is a crucial factor in vaccination decision-making, while 70.4% responded that vaccine price is an essential factor. If the younger age of participants who possessed lower monthly household income and agreed that the doctor’s recommendation is an important factor in vaccine decision making, the probability of accepting vaccine was more chance than those of older age participants.

Conclusions: The study highlighted that majority of the respondents wanted to accept the vaccine although they were concerned about the side effects and political unrest. It is the recommended to develop a strategy successfully to strengthen vaccine convenience.



Acceptability, COVID-19 vaccine, Hesitancy, Spring crisis

Full Text:



Bono SA, Faria de Moura Villela E, Siau CS, Chen WS, Pengpid S, et al. Factors affecting COVID-19 vaccine acceptance: an international survey among low-and middle-income countries. Vaccines. 2021;9(5):515.

Malik AA, McFadden SM, Elharake J, Omer SB. Determinants of COVID-19 vaccine acceptance in the US. E Clin Med. 2020;26:100495.

Paul E, Steptoe A, Fancourt D. Anti-vaccine attitudes and risk factors for not agreeing to vaccination against COVID-19 amongst 32,361 UK adults: implications for public health communications. Available at SSRN 3716874. 2020.

Machida M, Nakamura I, Kojima T, Saito R, Nakaya T, Hanibuchi T, et al. Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic. Vaccines. 2021;9(3):210.

Latkin CA, Dayton L, Yi G, Konstantopoulos A, Boodram B. Trust in a COVID-19 vaccine in the US: A social-ecological perspective. Soc Sci Med. 2021;270:113684.

Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nature Med. 2021;27(2):225-8.

Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey. Hum Vacc Immunother. 2021;17(6):1612-21.

Wong MC, Wong EL, Huang J, Cheung AW, Law K, Chong MK, et al. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine. 2021;39(7):1148-56.

Mannan DKA, Farhana KM. Knowledge, attitude and acceptance of a COVID-19 vaccine: a global cross-sectional study. Int Res J Business Soc Sci. 2020;6(4).

Eibensteiner F, Ritschl V, Nawaz FA, Fazel SS, Tsagkaris C, Kulnik ST, et al. People’s willingness to vaccinate against COVID-19 despite their safety concerns: Twitter poll analysis. J Med Internet Res. 2021;23(4):e28973.

El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and attitudes toward COVID-19 vaccines: a cross-sectional study from Jordan. PloS One. 2021;16(4):e0250555.

Puri N, Coomes EA, Haghbayan H, Gunaratne K. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Hum Vacc Immunother. 2020;16(11):2586-93.

Piltch-Loeb R, Savoia E, Goldberg B, Hughes B, Verhey T, Kayyem J, et al. Examining the effect of information channel on COVID-19 vaccine acceptance. PloS One. 2021;16(5):e0251095.

Dula J, Mulhanga A, Nhanombe A, Cumbi L, Júnior A, Gwatsvaira J, et al. COVID-19 vaccine acceptability and its determinants in Mozambique: an online survey. Vaccines. 2021;9(8):828.

Han SM, Lwin KS, Swe KT, Gilmour S, Nomura S. Military coup during COVID-19 pandemic and health crisis in Myanmar. BMJ Glob Health. 2021;6(4):e005801.

Mahase E. Covid-19: Military coup in Myanmar sees virus response crumble as doctors are arrested. Br Med J. 2021;372:n704.

Shepherd A. Myanmar medics resist military coup. BMJ. 2021;372:n368.

Soe ZW, Oo MM, Wah KS, Naing AT, Skalicky-Klein R, et al. Myanmar’s health leaders stand against military rule. Lancet. 2021;397(10277):875.

Jones I, Roy P. Sputnik V COVID-19 vaccine candidate appears safe and effective. Lancet. 2021;397(10275):642-3.

Dinleyici EC, Borrow R, Safadi MAP, van Damme P, Munoz FM. Vaccines and routine immunization strategies during the COVID-19 pandemic. Hum Vacc Immunother. 2021;17(2):400-7.

Guidry JP, Laestadius LI, Vraga EK, Miller CA, Perrin PB, Burton CW, et al. Willingness to get the COVID-19 vaccine with and without emergency use authorization. Am J Infect Control. 2021;49(2):137-42.

D’Apice C, Sarli L, Soe ZW. Myanmar: the ties between health and democracy. J Glob Health Rep. 2021;5:e2021076.

World Health Organization (WHO). Myanmar, Public Health Situation Analysis, 2021. Available from: m/item/myanmar-public-health-situation-analysis-29-may-2021. Accessed on 13 July 2021.

Lane S, MacDonald NE, Marti M, Dumolard L. Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017. Vaccine. 2018;36(26):3861-7.

Lancet T. Myanmar’s democracy and health on life support. Lancet. 2021;397(10279):1035.

DeRoo SS, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323(24):2458-9.

Frederiksen LSF, Zhang Y, Foged C, Thakur A. The long road toward COVID-19 herd immunity: vaccine platform technologies and mass immunization strategies. Front Immunol. 2020;11.

Cascini F, Pantovic A, Al-Ajlouni Y, Failla G, Ricciardi W. Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: a systematic review. E Clin Med. 2021;40:101113.

Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):160.

Trent M, Seale H, Chughtai AA, Salmon D, MacIntyre CR. Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: a comparative survey of five large cities in the United States, United Kingdom, and Australia. Vaccine. 2021.

Aloweidi A, Bsisu I, Suleiman A, Abu-Halaweh S, Almustafa M, Aqel M, et al. Hesitancy towards COVID-19 vaccines: an analytical cross-sectional study. Int J Environ Res Public Health. 2021;18(10):5111.

Soares P, Rocha JV, Moniz M, Gama A, Laires PA, Pedro AR, et al. Factors associated with COVID-19 vaccine hesitancy. Vaccines. 2021;9(3):300.

Chakraborty C, Sharma AR, Bhattacharya M, Agoramoorthy G, Lee SS. Asian-origin approved COVID-19 vaccines and current status of COVID-19 vaccination program in Asia: a critical analysis. Vaccines. 2021;9(6):600.